API Sector In India No Longer ‘Poor Cousin’ Of Formulations

 
• By Anju Ghangurde

The active pharmaceuticals ingredients segment in India appears to be coming into its own, alongside signs of a revival in the overall sales growth of Indian generic firms in FY2019, a study by an Indian investment banking and consulting services firm has indicated.

Brother-sister
THE API SECTOR HAS EMERGED AS AN OUTPERFORMER IN INDIA

More from India

More from Focus On Asia